These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6994422)

  • 1. Bromocriptine and Parkinson's disease: a 16-hour clinical evaluation.
    Grøn U; Friis ML; Pakkenberg H
    Acta Neurol Scand; 1980 Feb; 61(2):131-6. PubMed ID: 6994422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose bromocriptine in the early phases of Parkinson's disease.
    Tolosa E; Blesa R; Bayes A; Forcadell F
    Clin Neuropharmacol; 1987 Apr; 10(2):168-74. PubMed ID: 3332610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease: an open label trial of pergolide in patients failing bromocriptine therapy.
    Factor SA; Sanchez-Ramos JR; Weiner WJ
    J Neurol Neurosurg Psychiatry; 1988 Apr; 51(4):529-33. PubMed ID: 3288717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of bromocriptine and levodopa in Parkinson's disease.
    Godwin-Austen RB; Smith NJ
    J Neurol Neurosurg Psychiatry; 1977 May; 40(5):479-82. PubMed ID: 330825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose bromocriptine therapy in severe Parkinson's disease.
    Devathasan G; Chong PN; Puvanendran K; Lun KC; Wong PK
    Clin Neuropharmacol; 1984; 7(3):231-7. PubMed ID: 6386152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose bromocriptine therapy in Parkinson's disease: double-blind, placebo-controlled study.
    Staal-Schreinemachers AL; Wesseling H; Kamphuis DJ; vd Burg W; Lakke JP
    Neurology; 1986 Feb; 36(2):291-3. PubMed ID: 3511405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of lisuride and bromocriptine in the treatment of advanced Parkinson's disease.
    Laihinen A; Rinne UK; Suchy I
    Acta Neurol Scand; 1992 Dec; 86(6):593-5. PubMed ID: 1481646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromocriptine versus placebo in levodopa treated patients with Parkinson's disease.
    Gron U
    Acta Neurol Scand; 1977 Sep; 56(3):269-73. PubMed ID: 333855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained bromocriptine therapy in 50 previously untreated patients with Parkinson's disease.
    Stern GM; Lees AJ
    Adv Neurol; 1983; 37():17-21. PubMed ID: 6858771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of parkinson's disease with bromocriptine.
    Lieberman A; Kupersmith M; Estey E; Goldstein M
    N Engl J Med; 1976 Dec; 295(25):1400-4. PubMed ID: 989885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease: a comparison of mesulergine and bromocriptine.
    Burton K; Larsen TA; Robinson RG; Bratty PJ; Martin WR; Schulzer M; Calne DB
    Neurology; 1985 Aug; 35(8):1205-8. PubMed ID: 3895033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of pergolide and bromocriptine in patients with advanced Parkinson's disease.
    Lieberman AN; Neophytides A; Leibowitz M; Gopinathan G; Pact V; Walker R; Goodgold A; Goldstein M
    Adv Neurol; 1983; 37():95-108. PubMed ID: 6858782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment with high-dosage bromocriptine in advanced Parkinson's disease.
    Jansen EN; Meerwaldt JD
    Adv Neurol; 1987; 45():539-42. PubMed ID: 3103396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined bromocriptine-levodopa therapy early in Parkinson's disease.
    Rinne UK
    Neurology; 1985 Aug; 35(8):1196-8. PubMed ID: 4022354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromocriptine lessens the incidence of mortality in L-dopa-treated parkinsonian patients: prado-study discontinued.
    Przuntek H; Welzel D; Blümner E; Danielczyk W; Letzel H; Kaiser HJ; Kraus PH; Riederer P; Schwarzmann D; Wolf H
    Eur J Clin Pharmacol; 1992; 43(4):357-63. PubMed ID: 1451713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparisons of therapeutic effects of levodopa, levodopa and selegiline, and bromocriptine in patients with early, mild Parkinson's disease: three year interim report. Parkinson's Disease Research Group in the United Kingdom.
    BMJ; 1993 Aug; 307(6902):469-72. PubMed ID: 8400928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of bromocriptine on parkinsonism. A nation-wide collaborative double-blind study.
    Toyokura Y; Mizuno Y; Kase M; Sobue I; Kuroiwa Y; Narabayashi H; Uono M; Nakanishi T; Kameyama M; Ito H
    Acta Neurol Scand; 1985 Aug; 72(2):157-70. PubMed ID: 3901650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bromocriptine in the treatment of Parkinson's disease: a double-blind study against L-dopa/carbidopa.
    Gawel M; Riopelle R; Libman I; Bouchard S
    Adv Neurol; 1987; 45():535-8. PubMed ID: 3548263
    [No Abstract]   [Full Text] [Related]  

  • 19. [Combined treatment of the early stages of Parkinson's syndrome with bromocriptine and levodopa. The results of a multicenter study].
    Fischer PA; Przuntek H; Majer M; Welzel D
    Dtsch Med Wochenschr; 1984 Aug; 109(34):1279-83. PubMed ID: 6381019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with cabergoline in patients with advanced Parkinson's disease treated with levodopa.
    Marsden CD
    Drugs; 1998; 55 Suppl 1():17-22. PubMed ID: 9483166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.